Am J Med Genet B Neuropsychiatr Genet

1. MORENO-CALLE MT, Iniguez-Barrio S, Arrue MA, Erkoreka L, et al
   The Role of Glutamatergic and Dopaminergic Genes in Resistant Schizophrenia: A Systematic Review.
   Am J Med Genet B Neuropsychiatr Genet. 2026 Aug 25. doi: 10.1002/ajmg.b.70031.
   

   >> Share

   
   

   
   Am J Psychiatry

2. EDMOND KZ, Kaul D, Yusupov N, Kodel M, et al
   Association Between Age-Dependent DNA Methylation Changes at FKBP5 Enhancer Sites and Increased Cortical Gene Expression in Schizophrenia.
   Am J Psychiatry. 2026 Aug 26:appiajp20250473. doi: 10.1176/appi.ajp.20250473.
   

   >> Share

   
   

   
   Biol Psychiatry

3. TORRES-CARMONA E, Graff-Guerrero M, Nakajima S, Iwata Y, et al
   Machine Learning-Based Discrimination of Treatment-Resistant Schizophrenia Using Structural Brain Imaging: A Multi-Site Proof-of-Concept Study.
   Biol Psychiatry. 2026 Aug 22:S0006-3223(26)01489.
   

   >> Share

   
   

   
   BMJ

4. DAS-MUNSHI J, Grant-Rowles J, Stansfield J, Kirkbride JB, et al
   Social and structural inequalities should be central to schizophrenia management.
   BMJ. 2026;394:e100670.
   

   >> Share

   
   
5. SAWA A, Chiappelli J, Hamrah OP, Cascella NG, et al
   Schizophrenia: advances in pathophysiology, management, and precision medicine.
   BMJ. 2026;394:e635470.
   

   >> Share

   
   

   
   Br J Psychiatry

6. ZHOU H, Luo H, Siskind D, Northwood K, et al
   Incidence of clozapine-associated neutropenia in patients with schizophrenia: 20-year population-based study in Hong Kong.
   Br J Psychiatry. 2026 Aug 28:1-8. doi: 10.1192/bjp.2026.10726.
   

   >> Share

   
   

   
   Cortex

7. TOTZEK JF, Heckers S, Palaniyappan L, Young AL, et al
   Longitudinal inference of hippocampal volume and morphometric hippocampal-cortical covariance in psychosis.
   Cortex. 2026;204:154-169.
   

   >> Share

   
   

   
   J Clin Psychopharmacol

8. DE LEON J
   Are the 8 Finnish Deaths Explained by Agranulocytosis More Important than the Thousands of Suicide Deaths Associated with the Lack of Use of Clozapine? Reflections on Clozaphobia.
   J Clin Psychopharmacol. 2026;46:526-535.
   

   >> Share

   
   
9. DHALIWAL N, Kaladharan S, Waldmann J, Siskind D, et al
   Intramuscular Clozapine: A Systematic Scoping Review of Clinical Feasibility, Safety, and Efficacy.
   J Clin Psychopharmacol. 2026;46:625-635.
   

   >> Share

   
   
10. GROVER S, Kanwar J, Chakrabarti S
    Use of a Combination of Clozapine With a Long-Acting Injectable Antipsychotic: A Retrospective Study.
    J Clin Psychopharmacol. 2026;46:603-607.
    

    >> Share

    
    

    
    Mol Psychiatry

11. LI X, Chen M, Tang E, Fu J, et al
    HD-tDCS modulation of the DLPFC-HPC-EC pathway to enhance working memory in schizophrenia: a TMS-EEG Study.
    Mol Psychiatry. 2026 Aug 21. doi: 10.1038/s41380-026-03835.
    

    >> Share

    
    

    
    Neuropsychopharmacology

12. MAXIMO JO, Richman J, Lahti AC
    Trajectories of psychotic symptoms and fronto-parietal resting state functional connectivity MRI following an antipsychotic trial in medication-naive first-episode psychosis patients.
    Neuropsychopharmacology. 2026 Aug 21. doi: 10.1038/s41386-026-02515.
    

    >> Share

    
    

    
    PLoS One

13. STROUD RE, Hook K, Alemayehu M, Atwoli L, et al
    Demographic and clinical characteristics of participants in the Neuropsychiatric Genetics of African Populations-Psychosis (NeuroGAP-Psychosis) study: A descriptive analysis.
    PLoS One. 2026;21:e0356360.
    

    >> Share

    
    

    
    Psychiatry Res

14. SHEN Y, He YF, Guo QJ, Deng MH, et al
    Updated adjunctive minocycline for schizophrenia: A systematic review and meta-analysis of clinical and cognitive outcomes.
    Psychiatry Res. 2026;365:117399.
    

    >> Share

    
    
15. HU WT, Gu YT, Liu M, Yang J, et al
    Deficits in response inhibition of negative emotional faces in patients with schizophrenia and individuals with high schizotypal traits under explicit and implicit conditions.
    Psychiatry Res. 2026;365:117414.
    

    >> Share

    
    
16. DENG EK, Yan VK, Leung SM, Wei Y, et al
    Corrigendum to "Evolving patterns of antipsychotic use and polypharmacy for schizophrenia in Hong Kong: a 21-year longitudinal study" [Psychiatry Research 364 (2026) 117346].
    Psychiatry Res. 2026 Aug 13:117385. doi: 10.1016/j.psychres.2026.117385.
    

    >> Share

    
    
17. YIGLET Z, Kibralew G, Tadesse H, Molla W, et al
    Comparative effectiveness of olanzapine and risperidone on clinical outcomes of schizophrenia in a low-income country.
    Psychiatry Res. 2026;365:117400.
    

    >> Share

    
    
18. RYU S, Kim JW, Jhon M, Chung YC, et al
    Distinctive lexical profiles in Korean-speaking patients with schizophrenia: Analysis of verbal productivity, lexical diversity, and part-of-speech distributions.
    Psychiatry Res. 2026;365:117402.
    

    >> Share

    
    
19. ANDERSON JC, Ronksley PE, Kirkham JG, Crockford D, et al
    Factors associated with antipsychotic adherence in adults with schizophrenia - A real-world evaluation.
    Psychiatry Res. 2026;365:117406.
    

    >> Share

    
    

    
    Schizophr Res

20. BONFILS KA, Hammer LA, Subotnik KL, Ventura J, et al
    Relationships between empathy, symptoms, and functioning in first episode psychosis.
    Schizophr Res. 2026;297:263-269.
    

    >> Share

    
    
21. DIELEMANS DAM, Huizer K, van der Pluijm M, Thijssen A, et al
    Baseline inflammatory profile is associated with short-term antipsychotic-induced weight gain in first-episode psychosis: results from the OPTiMiSE study.
    Schizophr Res. 2026;297:254-262.
    

    >> Share

    
    
22. KITTLESON AR, Chatterjee A, Lebovitz J, Rogers BP, et al
    The embodied self in psychosis: Relationships among insula functional connectivity and emotional embodiment in schizophrenia-spectrum disorders.
    Schizophr Res. 2026;297:241-253.
    

    >> Share

    
    
23. MARCHI M, Travascio A, Pollice G, Grenzi P, et al
    Predictors of social and occupational functioning in help-seeking youths accessing an early intervention in psychosis programme: A real-world cohort study using machine learning algorithms.
    Schizophr Res. 2026;297:231-240.
    

    >> Share

    
    
24. WORTHY G, Cocks K, Pascoe B, Reaney M, et al
    Derivation of score interpretation thresholds in clinical outcome assessments measuring cognitive impairment associated with schizophrenia.
    Schizophr Res. 2026;297:219-227.
    

    >> Share

    
    
25. NOWICKA M, Jarczewska-Gerc E, Marszal-Wisniewska M
    Letter to the editor: Application of mental simulation and implementation intentions in the therapeutic management of drug-resistant auditory hallucinations in schizophrenia - Preliminary study.
    Schizophr Res. 2026;297:213-218.
    

    >> Share

    
    
26. MOYAL M, Consoloni T, Haroche A, Sebille SB, et al
    Anterior cingulate cortex sulcal patterns associated with catatonia across schizophrenia and mood disorders.
    Schizophr Res. 2026;297:202-210.
    

    >> Share

    
    
27. AKOURI-SHAN L, Le TP, Firmin R, Ventura J, et al
    Self-stigma and stigma resistance after a first episode of psychosis: Clinical, cognitive, and functional correlates.
    Schizophr Res. 2026;297:191-193.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share